FDA Adverse Event Injury Summary report: N

UNICEL® DXC 800 SYNCHRON® SYSTEM

MDR report key: 2200431 · Received August 11, 2011

Report

Report Number
2050012-2011-04255
Event Type
Injury
Date Received
August 11, 2011
Date of Event
July 27, 2011
Report Date
July 27, 2011
Manufacturer
BECKMAN COULTER, INC.
Product Code
CEO
PMA / PMN Number
K042291
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

BECKMAN COULTER INC. CUSTOMER TECHNICAL SERVICES GUIDED THE CUSTOMER THROUGH INSTRUMENT TROUBLESHOOTING. THE CUSTOMER PERFORMED A CUP CLEANING PROCEDURE, A LAMP CALIBRATION, AND AN INSTRUMENT CALIBRATION AND ASSAY QUALITY CONTROL ASSESSMENT. THE CUSTOMER ADVISED THAT THEY WOULD CONTACT BECKMAN COULTER IF THE TROUBLESHOOTING DID NOT RESOLVE THE CUSTOMER. NO CUSTOMER FEEDBACK REPORTS HAS BEEN RECEIVED FROM THIS CUSTOMER SINCE THE TIME OF THIS EVENT WITH A SIMILAR ISSUE. ALTHOUGH ADJUSTMENTS WERE MADE TO THE INSTRUMENT BEFORE RETURNING IT INTO SERVICE, A DEFINITIVE ROOT CAUSE FOR THIS EVENT HAS NOT BEEN DETERMINED TO DATE.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT ON (B)(6) 2011 AN ERRONEOUSLY LOW PHOSPHORUS (PHOSM) RESULT WAS GENERATED FROM A UNICEL DXC 800 SYNCHRON SYSTEM FOR ONE PATIENT SAMPLE. THE INITIAL RESULT WAS RELEASED FROM THE LABORATORY AND THE PATIENT RECEIVED MEDICAL TREATMENT BECAUSE OF THE LOW RESULT. THE DETAILS OF PATIENT TREATMENT ARE CURRENTLY UNKNOWN. THE SAMPLE WAS RETESTED ON THE SAME INSTRUMENT, AS WELL AS ANOTHER INSTRUMENT. THE REPEAT RESULTS WERE HIGHER. NO SAMPLE COLLECTION/HANDLING INFORMATION WAS PROVIDED BY THE CUSTOMER. INSTRUMENT PHOSM QUALITY CONTROL RESULTS DURING THE TIMEFRAME OF THE EVENT WERE WITHIN CUSTOMER SPECIFICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL® DXC 800 SYNCHRON® SYSTEM CLINICAL CHEMISTRY ANALYZER CEO BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention